Summaries for Costello Syndrome

Sources:
30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 15GeneReviews, 22MalaCards
See all sources

Export this MalaCard
NIH Rare Diseases: Costello syndrome is characterized by delayed development and intellectual disability, distinctive facial features, loose folds of extra skin (especially on the hands and feet), and unusually flexible joints. Heart abnormalities are common, including an unusually fast heartbeat (tachycardia), structural heart defects, and a form of heart disease that enlarges and weakens the heart muscle (hypertrophic cardiomyopathy). Beginning in early childhood, people with Costello syndrome are at an increased risk of developing certain cancerous and noncancerous tumors. Costello syndrome is caused by mutations in the HRAS gene. It is considered an autosomal dominant condition, but almost all reported cases have resulted from new gene mutations and have occurred in people with no history of the disorder in their family. The signs and symptoms of Costello syndrome overlap significantly with those of two other genetic conditions, cardiofaciocutaneous (CFC) syndrome and Noonan syndrome. While the three conditions are distinguished by their genetic cause and specific patterns of signs and symptoms, it can be difficult to tell them apart in infancy.30

MalaCards: Costello Syndrome, also known as faciocutaneoskeletal syndrome, is related to hyperinsulinemic hypoglycemia and cardiofaciocutaneous syndrome. An important gene associated with Costello Syndrome is HRAS (v-Ha-ras Harvey rat sarcoma viral oncogene homolog), and among its related pathways are Renal cell carcinoma and Pathways in cancer. The compounds c-peptide and pge2 have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and heart, and related mouse phenotypes are endocrine/exocrine gland and liver/biliary system.

Genetics Home Reference: Costello syndrome is a disorder that affects many parts of the body. This condition is characterized by delayed development and intellectual disability, loose folds of skin (which are especially noticeable on the hands and feet), unusually flexible joints, and distinctive facial features including a large mouth. Heart problems are common, including an abnormal heartbeat (arrhythmia), structural heart defects, and a type of heart disease that enlarges and weakens the heart muscle (hypertrophic cardiomyopathy). Infants with Costello syndrome may be larger than average at birth, but most have difficulty feeding and grow more slowly than other children. People with this condition have relatively short stature and may have reduced growth hormone levels. Other signs and symptoms of Costello syndrome can include tight Achilles tendons (which connect the calf muscles to the heel), weak muscle tone (hypotonia), a structural abnormality of the brain called a Chiari I malformation, skeletal abnormalities, dental problems, and problems with vision.17

Wikipedia: Costello syndrome, also called faciocutaneoskeletal syndrome or FCS syndrome, is a rare genetic disorder...44 more...

OMIM: 218040

GeneReviews summary for costello

Aliases & Descriptions for Costello Syndrome

Sources:
6Disease Ontology, 7diseasecard, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 8DISEASES, 33OMIM, 43UMLS, 24MeSH
See all sources

Aliases & Descriptions:

costello syndrome 6 7 15 30 16 17 8 33
faciocutaneoskeletal syndrome 6 30 17
fcs syndrome 6 30 17
costello syndrome (disorder) 43

External Ids:

Related Diseases for Costello Syndrome

Sources:
13GeneCards, 14GeneDecks
See all sources

Diseases related to costello syndrome by text searches and GeneDecks gene sharing:

(show top 50)    (show all 234)
idRelated DiseaseScoreTop Affiliating Genes
1hyperinsulinemic hypoglycemia28.5INS, IGF2
2cardiofaciocutaneous syndrome27.4BRAF, MAP2K2, MAP2K1, HRAS, PTPN11, KRAS
3hypoglycemia26.3INS, IGF2, IGFBP3, IGF1
4noonan syndrome26.1BRAF, MAP2K2, MAP2K1, IGFBP3, IGF1, HRAS
5was-related disorders25.5BRAF, INS, MAP2K2, MAP2K1, IGF1, HRAS
6rhabdomyosarcoma24.6INS, MB, MAP2K2, MAP2K1, IGF2, IGF1
7supravalvular aortic stenosis13.4FBLN5, ELN
8spitz nevus13.4BRAF, HRAS
9fbln5-related cutis laxa13.4FBLN5, ELN
10penile cancer13.4HRAS, KRAS
11connective tissue disease13.3MFAP2, FBLN5, ELN
12noonan-like/multiple giant cell lesion syndrome13.3PTPN11, SOS1
13anthrax disease13.2BRAF, MAP2K2, MAP2K1
14lymphoproliferative syndrome13.2HRAS, PTPN11, KRAS
15lichen sclerosus13.1VCAN, KRAS, ELN
16developmental disabilities13.0BRAF, HRAS, PTPN11, ELN
17mucopolysaccharidosis13.0IGF2, GLB1, ELN
18lymphangioleiomyomatosis13.0IGF2, GLB1, ELN
19myeloproliferative disorder13.0IL18R1, HRAS, PTPN11
20pulmonary valve stenosis13.0MAP2K2, PTPN11, ELN, SOS1
21carpal tunnel syndrome12.9VCAN, INS, ELN
22hypoglycemic coma12.9INS, IGF2
23nevus12.9BRAF, MB, HRAS, ELN
24ichthyosis12.9BRAF, MAP2K2, MAP2K1, KRAS
25angiofibroma12.9VCAN, IGF2, PDGFB
26mental retardation syndrome12.8BRAF, HRAS, PTPN11, ELN
27empty sella syndrome12.8INS, IGFBP3
28alcohol abuse12.7BRAF, MB, KRAS
29abdominal aortic aneurysm12.7VCAN, GLB1, PDGFB, ELN
30aortic aneurysm12.7VCAN, MFAP2, FBLN5, GLB1, PDGFB, ELN
31myelomonocytic leukemia12.7BRAF, PTPN11, KRAS, SOS1
32gallbladder carcinoma12.6BRAF, IGF2, HRAS, KRAS
33viral infectious disease12.6IL18R1, MB, MAP2K1, HRAS, PTPN11
34orbit embryonal rhabdomyosarcoma12.6MB, IGF1, HRAS
35juvenile myelomonocytic leukemia12.5BRAF, HRAS, PTPN11, KRAS, SOS1
36granular cell tumor12.5MB, IGF1, PTPN11
37pleomorphic adenoma12.5VCAN, IGF2, HRAS, KRAS, ELN
38hemangioma12.5MAP2K2, MAP2K1, IGF2, PDGFB, KRAS
39donohue syndrome12.5INS, IGF1
40intrauterine and postnatal growth retardation12.5IGF2, IGF1
41germ cell cancer12.5INS, IGF1, HRAS
42lynch syndrome12.5BRAF, IGF1, KRAS
43retinal detachment12.5IGF1, PDGFB, ELN
44acute lymphoblastic leukemia12.5IL18R1, HRAS, PTPN11, KRAS
45congenital heart defect12.4BRAF, MAP2K2, MAP2K1, HRAS, PTPN11, SOS1
46diffuse idiopathic skeletal hyperostosis12.4IGFBP3, IGF1
47neurofibromatosis12.4IGFBP3, HRAS, PTPN11, KRAS
48keloids12.4VCAN, FBLN5, IGF1, ELN
49lung benign neoplasm12.4MAP2K1, IGFBP3, HRAS, PDGFB, KRAS
50idiopathic juvenile osteoporosis12.4IGFBP3, IGF1

Graphical network of the top 20 diseases related to costello syndrome:



Graphical network of diseases related to costello syndrome

Clinical Features for Costello Syndrome

Sources:
33OMIM
See all sources
Clinical features from OMIM: 218040

Drugs & Therapeutics for Costello Syndrome

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for costello syndrome

Drug clinical trials:

Search ClinicalTrials for costello syndrome

Search NIH Clinical Center for costello syndrome

Search CenterWatch for costello syndrome

Genetic Tests for Costello Syndrome

Sources:
16GeneTests
See all sources

Genetic tests related to costello syndrome:

id Genetic test Affiliating Genes
1 Costello Syndrome
clinical/research
HRAS

Anatomical Context for Costello Syndrome

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to costello syndrome:

22
Brain, Spinal cord, Heart, Skeletal muscle, Skin

Phenotypes for genes affiliated with Costello Syndrome

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to costello syndrome:

25 (show all 23)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1endocrine/exocrine gland phenotypeMP:000537910.1KRAS
2liver/biliary system phenotypeMP:00053709.7GLB1, INS
3immune system phenotypeMP:00053879.5KRAS, PTPN11, BRAF
4craniofacial phenotypeMP:00053829.1SOS1, PTPN11, MAP2K1, MAP2K2, FBLN5, CHST11
5reproductive system phenotypeMP:00053899.1KRAS, PDGFB, PTPN11, HRAS, GLB1, MAP2K1
6respiratory system phenotypeMP:00053889.0ELN, SHOC2, PDGFB, MB, FBLN5, CHST11
7tumorigenesisMP:00020068.8BRAF, IGF1, HRAS, PTPN11, KRAS
8integument phenotypeMP:00107718.6SOS1, SHOC2, KRAS, PTPN11, HRAS, MAP2K1
9embryogenesis phenotypeMP:00053808.6SOS1, SHOC2, KRAS, PTPN11, MAP2K1, MB
10limbs/digits/tail phenotypeMP:00053718.5KRAS, IGF2, CHST11, VCAN
11mortality/agingMP:00107688.4SOS1, SHOC2, PTPN11, HRAS, GLB1, MB
12renal/urinary system phenotypeMP:00053677.7KRAS, PDGFB, HRAS, GLB1, IGF2, INS
13nervous system phenotypeMP:00036317.6KRAS, PTPN11, HRAS, GLB1, IGF2, INS
14digestive/alimentary phenotypeMP:00053817.6SOS1, KRAS, PTPN11, IGF2, MAP2K1, MAP2K2
15normal phenotypeMP:00028737.4SHOC2, KRAS, PTPN11, HRAS, IGF1, MAP2K2
16vision/eye phenotypeMP:00053917.4SOS1, KRAS, PDGFB, PTPN11, IGF2, MAP2K1
17skeleton phenotypeMP:00053907.4PTPN11, HRAS, IGF1, IGF2, INS, CHST11
18muscle phenotypeMP:00053696.7SOS1, ELN, KRAS, PDGFB, PTPN11, IGF1
19growth/size phenotypeMP:00053786.5SOS1, SHOC2, KRAS, PDGFB, PTPN11, HRAS
20hematopoietic system phenotypeMP:00053976.5SOS1, KRAS, PDGFB, PTPN11, GLB1, IGF1
21cellular phenotypeMP:00053846.3IGF1, GLB1, PTPN11, KRAS, SOS1, IGF2
22cardiovascular system phenotypeMP:00053855.8PTPN11, PDGFB, KRAS, SHOC2, ELN, SOS1
23homeostasis/metabolism phenotypeMP:00053764.7BRAF, SOS1, ELN, SHOC2, KRAS, PDGFB

Publications for genes affiliated with Costello Syndrome

Sources:
35PubMed
See all sources

Articles related to costello syndrome:

(show all 36)
idTitleAuthorsYearAffiliating Genes
1Molecular confirmation of HRAS p.G12S in siblings wit h Costello syndrome. (21834037)Gripp K.W.... Sol-Church K.2011HRAS
2High incidence of progressive postnatal cerebellar en largement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities. (20425820)Gripp K.W.... Dobyns W.B.2010HRAS
3Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. (19132118)Santoriello C.... Mione M.2009HRAS
4Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome. (19035362)Rosenberger G.... Kutsche K.2009HRAS
5Prenatal features of Costello syndrome: ultrasonograp hic findings and atrial tachycardia. (19382114)Lin A.E.... Gripp K.W.2009HRAS
6Costello syndrome H-Ras alleles regulate cortical dev elopment. (19371735)Paquin A.... Miller F.D.2009HRAS
7Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism. (19206176)Sol-Church K.... Gripp K.W.2009HRAS
8Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype? (18247425)Gripp K.W.... Sol-Church K.2008HRAS
9Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation. (17979197)Denayer E.... Legius E.2008HRAS
10Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome. (18042262)Schulz A.L.... Zenker M.2008HRAS, MAP2K1, BRAF
11Severe neonatal manifestations of Costello syndrome. (18039947)Lo I.F.... Kerr B.2008HRAS
12Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome. (17366577)Narumi Y.... Matsubara Y.2007HRAS, MAP2K1, BRAF
13HRAS and the Costello syndrome. (17250658)Rauen K.A.2007IL18R1
14Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. (17054105)Zampino G.... Tartaglia M.2007HRAS
15Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. (17704260)Nava C.... Cave H.2007MAP2K1, BRAF, MAP2K2
16Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome. (17551924)Gripp K.W.... Sol-Church K.2007MAP2K1, BRAF
17Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. (17164262)Kratz C.P.... Zenker M.2007HRAS
18Costello syndrome and related disorders. (18025929)Quezada E.... Gripp K.W.2007HRAS, MAP2K2
19HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. (16329078)Gripp K.W.... Sol-Church K.2006HRAS
20The IGF system in a case of Costello syndrome. (16682842)Barreca A.... Lorini R.2006IGF1, IGFBP3, IGF2
21Somatic mosaicism for an HRAS mutation causes Costello syndrome. (16969868)Gripp K.W.... Sol-Church K.2006HRAS
22Significant decrease in tropoelastin gene expression in fibroblasts from a Japanese Costello syndrome patient with impaired elastogenesis and enhanced proliferation. (16829682)Tatano Y.... Itoh K.2006GLB1, ELN, FBLN5
23Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. (16443854)Kerr B.... Black G.2006HRAS
24Recurring HRAS mutation G12S in Dutch patients with Costello syndrome. (16881968)van Steensel M.A.... van Geel M.2006HRAS
25Costello syndrome and hyperinsulinemic hypoglycemia. (16278907)Alexander S.... Hussain K.2005INS
26Germline mutations in HRAS proto-oncogene cause Costello syndrome. (16170316)Aoki Y.... Matsubara Y.2005HRAS
27Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. (14695326)Hinek A.... Wight T.N.2004GLB1, ELN, VCAN
28Disruption of the PDGFB gene in a 1;22 translocation patient does not cause Costello syndrome. (15081117)Sutajova M.... Kutsche K.2004PDGFB
29Costello syndrome: an overview. (12561057)Hennekam R.C.2003GLB1
30Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes. (12752577)Tartaglia M.... Rauen K.A.2003PTPN11
31No mutation in the gene for Noonan syndrome, PTPN11, in 18 patients with Costello syndrome. (12900909)TrAPger B.... Meinecke P.2003PTPN11
32Refinement and delineation of the breakpoint regions of a chromosome 1;22 translocation in a patient with Costello syndrome. (11977185)Maroti Z.... Solyom E.2002HRAS
33Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. (10712202)Hinek A.... Weksberg R.2000GLB1, ELN
34Costello syndrome with decreased gene expression of elastin in cultured dermal fibroblasts. (11146354)Hatamochi A.... Kobayashi K.2000ELN
35Elastic fiber degeneration in Costello syndrome. (8834040)Mori M.... Momoi M.Y.1996MB
36Costello Syndrome (20301680)Gripp K.W.... Lin A.E.1993HRAS

Expression for genes affiliated with Costello Syndrome

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Costello Syndrome

Pathways for genes affiliated with Costello Syndrome

Sources:
20KEGG, 34PharmGKB, 36QIAGEN, 10EMD Millipore, 41Thomson Reuters, 37R&D Systems, 3Cell Signaling Technology
See all sources

Pathways related to costello syndrome according to GeneDecks:

(show top 50)    (show all 286)
idPathwayScoreTop Affiliating Genes
1Renal cell carcinoma2010.0SOS1, PDGFB, HRAS, MAP2K2
2Pathways in cancer2010.0KRAS
3Sorafenib Pharmacodynamics349.6KRAS, HRAS, MAP2K1, BRAF
4OSM Pathway369.5BRAF, MAP2K2, MAP2K1, HRAS, SOS1
5Pathway_PA165959425349.5KRAS, MAP2K2, HRAS, MAP2K1, BRAF
6Immune response IL-6 signaling pathway109.5SOS1, PTPN11, HRAS, MAP2K1, MAP2K2
7Immune response_IL-6 signaling pathway419.5MAP2K2, MAP2K1, HRAS, SOS1, PTPN11
8Pathway_PA165980050349.5HRAS, MAP2K1, BRAF, KRAS, MAP2K2
9Thyroid cancer209.4BRAF, KRAS, MAP2K2, MAP2K1, HRAS
10G-protein signaling_Ras family GTPases in kinase cascades (scheme)419.4HRAS, BRAF, MAP2K2, KRAS, MAP2K1
11G-protein signaling Ras family GTPases in kinase cascades (scheme)109.4HRAS, MAP2K1, KRAS, MAP2K2, BRAF
12Development Neurotrophin family signaling109.4HRAS, SOS1, MAP2K1, BRAF, MAP2K2, PTPN11
13Development_Neurotrophin family signaling419.4BRAF, MAP2K1, HRAS, PTPN11, SOS1, MAP2K2
14Neurotrophin signaling pathway209.3PTPN11, MAP2K1, HRAS, MAP2K2, BRAF, SOS1
15Development CNTF receptor signaling109.3MAP2K1, SOS1, PTPN11, HRAS, MAP2K2
16Common Cytokine Receptor Gamma-Chain Family Signaling Pathways379.3MAP2K2, MAP2K1, SOS1, KRAS, BRAF
17IL-2 Signaling Pathways379.3KRAS, MAP2K2, BRAF, MAP2K1, SOS1
18Endometrial cancer209.2BRAF, MAP2K2, MAP2K1, HRAS, KRAS, SOS1
19Non-small cell lung cancer209.2BRAF, MAP2K2, MAP2K1, HRAS, KRAS, SOS1
20Development_CNTF receptor signaling419.2SOS1, HRAS, MAP2K1, PTPN11
21Acute myeloid leukemia209.2MAP2K1, SOS1, BRAF, KRAS, HRAS, MAP2K2
22Gap junction209.0MAP2K1, SOS1, KRAS, PDGFB, MAP2K2, HRAS
23Chronic myeloid leukemia209.0HRAS, SOS1, KRAS, PTPN11, MAP2K1, MAP2K2
24MAP Kinase Signaling38.9SOS1, KRAS, BRAF, MAP2K1, PTPN11, MAP2K2
25ErbB signaling pathway208.9MAP2K1, HRAS, KRAS, SOS1, MAP2K2, BRAF
26Long-term depression208.9BRAF, MAP2K2, MAP2K1, KRAS, HRAS, IGF1
27Natural killer cell mediated cytotoxicity208.9HRAS, MAP2K2, PTPN11, KRAS, SOS1, MAP2K1
28Development IGF-RI signaling108.8IGF2, MAP2K1, IGFBP3, IGF1, HRAS
29Molecular Mechanisms of Cancer368.8IGF2, PDGFB, MAP2K2, MAP2K1, HRAS, SOS1
30Melanoma208.8PDGFB, IGF1, MAP2K1, MAP2K2, BRAF, KRAS
31IGF1R Signaling368.5MAP2K1, SOS1, IGF2, HRAS, BRAF, MAP2K2
32Glioma208.5PDGFB, BRAF, MAP2K2, HRAS, MAP2K1, KRAS
33Transcription Receptor-mediated HIF regulation108.4IGF1, SOS1, IGFBP3, MAP2K1, INS
34Glioblastoma Multiforme368.4IGF1, IGF2, MAP2K1, BRAF, HRAS, MAP2K2
35Insulin signaling pathway208.3MAP2K1, BRAF, INS, MAP2K2, SOS1, KRAS
36TGF-Beta Pathway368.3SOS1, PDGFB, IGF2, HRAS, IGF1, MAP2K1
37Nanog in Mammalian ESC Pluripotency368.3PDGFB, IGF1, IGF2, MAP2K1, HRAS, MAP2K2
38Adipocytokines & Insulin Signaling378.3INS, MAP2K2, MAP2K1, PTPN11, KRAS, SOS1
39Development_IGF-1 receptor signaling418.3SOS1, HRAS, MAP2K1, MAP2K2, IGF2, IGFBP3
40Rap1 Pathway368.3IGF1, IGF2, MAP2K1, HRAS, MAP2K2, SOS1
41Ras Pathway368.3MAP2K2, BRAF, MAP2K1, IGF2, IGF1, HRAS
42Regulation of actin cytoskeleton208.1MAP2K2, INS, BRAF, SOS1, PDGFB, HRAS
43MAPK Family Pathway368.0IGF1, IL18R1, MAP2K2, PDGFB, MAP2K1, SOS1
44PTEN Pathway368.0ELN, SOS1, HRAS, BRAF, MAP2K2, MAP2K1
45GPCR Pathway368.0IGF2, MAP2K1, BRAF, IGF1, PDGFB, SOS1
46Transcription_Receptor-mediated HIF regulation418.0SOS1, IGF1, IGFBP3, MAP2K1, MAP2K2, INS
47MAPK Signaling367.8IGF2, MAP2K2, MAP2K1, IGF1, HRAS, PDGFB
48p70S6K Signaling367.8MAP2K2, MAP2K1, IGF2, IGF1, HRAS, INS
49Prostate cancer207.7SOS1, MAP2K2, MAP2K1, IGF1, INS, BRAF
50eIF2 Pathway367.5MAP2K1, MAP2K2, INS, BRAF, IGF2, IGF1

Compounds for genes affiliated with Costello Syndrome

Sources:
32Novoseek , 9DrugBank, 18HMDB, 34PharmGKB, 42Tocris Bioscience
See all sources

Compounds related to costello syndrome according to GeneDecks:

(show top 50)    (show all 100)
idCompoundScoreTop Affiliating Genes
1c-peptide32 10.2IGF2
2pge232 9.9MB, MAP2K1
3aprotinin32 9 9 11.8IGF1, MAP2K1, MB
4dermatan32 18 10.6ELN, CHST11, VCAN
5h2o232 9.6MB, MAP2K1, PTPN11, ELN
6ly29400232 9.6KRAS, PTPN11, HRAS, MAP2K1, IL18R1
72,4-dinitrophenol32 9.4IGF1, IGF2, ELN
8alginate32 9.4ELN, MB, IGF1, VCAN
9phosphotyrosine32 9.1MAP2K1, PDGFB, PTPN11, HRAS, IGF2, IL18R1
10pd 98,05932 9.1MAP2K2, BRAF, PDGFB, MAP2K1, IGF1, HRAS
11hyaluronic acid32 18 10.1MFAP2, IGFBP3, MB, VCAN, ELN
12megestrol acetate32 9.0IGF1, IGFBP3, IGF2
13pegvisomant32 9 9 11.0IGF2, IGFBP3, IGF1
14phosphoinositide32 9.0PTPN11, KRAS, BRAF, IL18R1, MAP2K2, MAP2K1
15procollagen32 8.9IGF1, IGFBP3, IL18R1, ELN, PDGFB
16mecasermin32 9 9 10.9IGF1, INS, IGFBP3
17imatinib32 34 9 9 11.9MAP2K1, BRAF, IGF2, KRAS, PDGFB, PTPN11
18oxandrolone32 9 9 10.9INS, IGFBP3, IGF1
19agar32 8.8PDGFB, PTPN11, HRAS, IGF2, MAP2K1, BRAF
20tgf beta132 8.7VCAN, PDGFB, MAP2K1, IGF2, ELN, IGFBP3
21paclitaxel32 34 9 9 11.5MAP2K1, IGFBP3, HRAS, KRAS, BRAF, IGF2
22paraffin32 8.5BRAF, MB, IGF2, HRAS, PDGFB, KRAS
23oligonucleotide32 8.3HRAS, IL18R1, PTPN11, PDGFB, KRAS, BRAF
24dehydroepiandrosterone sulfate32 8.3INS, IGF2, IGF1, IGFBP3
25cysteine32 8.3IL18R1, MB, MAP2K1, IGF2, HRAS, IGFBP3
26octreotide32 42 9 9 11.3IGF1, IGF2, IGFBP3, INS
27dhea32 8.2IGF1, IGFBP3, IGF2, INS
28valine32 8.2MB, BRAF, IGFBP3, HRAS, IGF2, KRAS
29cycloheximide32 8.1IGF2, MAP2K2, ELN, PDGFB, MAP2K1, IGFBP3
30rapamycin32 42 9.1IL18R1, BRAF, INS, IGF2, HRAS, ELN
31thyroxine32 18 8.9MB, IGF1, IGFBP3, IGF2, INS
32progesterone32 42 9 18 9 11.9BRAF, IL18R1, MAP2K1, IGF2, IGFBP3, IGF1
33wortmannin32 42 8.9KRAS, IGF1, MAP2K1, HRAS, MAP2K2, INS
34glutamine32 7.9MB, IGF2, IGFBP3, IGF1, HRAS, IL18R1
35thymidine32 18 8.9PTPN11, GLB1, IGF1, IGFBP3, IGF2, MAP2K1
36gnrh32 7.8IGF1, INS, MAP2K1, IGF2, IGFBP3
37glutamate32 7.8IGF2, PTPN11, IGFBP3, BRAF, MAP2K1, INS
38cisplatin32 34 9 9 10.7KRAS, IL18R1, MB, MAP2K1, IGF2, IGFBP3
39androstenedione32 18 8.7IGF2, IGFBP3, INS, IGF1
40retinoic acid32 42 18 9.4IGFBP3, BRAF, IL18R1, MAP2K1, IGF2, HRAS
41testosterone32 9 18 9 10.2IGFBP3, IGF2, IGF1, ELN, MAP2K1, MB
42alanine32 7.1IGF2, BRAF, IL18R1, MB, MAP2K1, IGFBP3
43dexamethasone32 42 34 9 9 11.1ELN, IL18R1, IGF2, IGFBP3, INS, IGF1
44phosphatidylinositol32 6.8BRAF, SOS1, KRAS, PTPN11, HRAS, IGF1
45glucose32 6.6BRAF, VCAN, INS, IL18R1, IGFBP3, IGF1
46arginine32 6.5HRAS, ELN, BRAF, INS, IL18R1, MB
47estrogen32 6.4IGFBP3, IGF2, MAP2K1, IGF1, HRAS, ELN
48tyrosine32 6.4MAP2K1, PTPN11, IGF2, BRAF, MFAP2, PDGFB
49vegf32 6.2ELN, HRAS, IGF1, IGF2, IGFBP3, MAP2K1
50serine32 5.3SOS1, ELN, KRAS, PDGFB, BRAF, MAP2K1

GO Terms for genes affiliated with Costello Syndrome

Sources:
12Gene Ontology
See all sources

Cellular components related to costello syndrome according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1insulin-like growth factor binding protein complexGO:0169429.3IGFBP3, IGF1

Biological processes related to costello syndrome according to GeneDecks:

(show all 27)
idNameGO IDScoreTop Affiliating Genes
1activation of MAPKK activityGO:00018610.6MAP2K2
2regulation of early endosome to late endosome transportGO:200064110.2MAP2K1, MAP2K2
3regulation of Golgi inheritanceGO:09017010.2MAP2K1, MAP2K2
4regulation of stress-activated MAPK cascadeGO:03287210.1MAP2K2, MAP2K1
5positive regulation of Rac protein signal transductionGO:03502210.0KRAS, HRAS
6positive regulation of protein serine/threonine kinase activityGO:0719029.8IGF2, MAP2K1, MAP2K2
7positive regulation of Ras protein signal transductionGO:0465799.8SHOC2, IGF1, MAP2K1
8regulation of synaptic transmission, GABAergicGO:0322289.6HRAS, KRAS
9leukocyte migrationGO:0509009.5SOS1, KRAS, PTPN11, HRAS
10epidermal growth factor receptor signaling pathwayGO:0071739.2SOS1, KRAS, PTPN11, HRAS, MAP2K1, MAP2K2
11axon guidanceGO:0074119.2SOS1, KRAS, PTPN11, HRAS, MAP2K1, MAP2K2
12positive regulation of insulin receptor signaling pathwayGO:0466289.1INS, IGF2
13small GTPase mediated signal transductionGO:0072649.1SOS1, KRAS, HRAS, MAP2K1, MAP2K2, BRAF
14positive regulation of phosphatidylinositol 3-kinase cascadeGO:0140689.1INS, IGF1, PDGFB
15positive regulation of DNA replicationGO:0457409.0PDGFB, HRAS, IGF1, INS
16MAPK cascadeGO:0001659.0KRAS, HRAS, MAP2K1, MAP2K2, INS
17nerve growth factor receptor signaling pathwayGO:0480118.9SOS1, KRAS, PTPN11, HRAS, MAP2K1, MAP2K2
18positive regulation of glycogen biosynthetic processGO:0457258.9IGF1, IGF2, INS
19Ras protein signal transductionGO:0072658.8SOS1, SHOC2, KRAS, HRAS, IGF1, MAP2K1
20blood coagulationGO:0075968.8SOS1, KRAS, PDGFB, PTPN11, HRAS, IGF1
21positive regulation of mitosisGO:0458408.7INS, IGF2, IGF1, PDGFB
22fibroblast growth factor receptor signaling pathwayGO:0085438.7BRAF, SOS1, SHOC2, KRAS, PTPN11, HRAS
23positive regulation of peptidyl-tyrosine phosphorylationGO:0507318.7PDGFB, IGF1, IGF2, INS
24positive regulation of protein kinase B signaling cascadeGO:0518978.5IGF1, IGF2, INS
25positive regulation of cell proliferationGO:0082848.0KRAS, PDGFB, HRAS, IGF1, IGF2, INS
26positive regulation of MAPK cascadeGO:0434107.9PDGFB, HRAS, IGF1, IGFBP3, IGF2, INS
27insulin receptor signaling pathwayGO:0082867.9SOS1, KRAS, PTPN11, HRAS, IGF2, MAP2K1

Molecular functions related to costello syndrome according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1protein serine/threonine kinase activator activityGO:0435399.4MAP2K2, MAP2K1, IGF2
2insulin receptor bindingGO:0051588.3INS, IGF2, IGF1, PTPN11
3insulin-like growth factor receptor bindingGO:0051598.3IGF1, IGF2, INS
4protein bindingGO:0055155.1ELN, KRAS, PDGFB, PTPN11, HRAS, GLB1

Sources for Costello Syndrome

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS